| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
1 Institute of Pathology and 2 Department of Obstetrics and Gynecology, University Hospital Freiburg, and 3 Center for Dermatopathology, Freiburg, Germany
Requests for reprints: Axel zur Hausen, Institute of Pathology, University Hospital Freiburg, P.O. Box 214, 79002 Freiburg, Germany. Phone: 49-761-2708067; Fax: 49-761-2708004; E-mail: axel.zurhausen{at}uniklinik-freiburg.de.
Key Words: polyomavirus MCPyV Merkel cell carcinoma carcinogenesis
Merkel cell carcinoma (MCC) is a rare but very aggressive human malignancy of the elderly or immunosuppressed patients. Recently, the clonal integration of a new human polyoma virus, which was termed Merkel cell polyomavirus (MCPyV), has been reported in 8 of 10 MCC patients. In the present study, we studied the formalin-fixed and paraffin-embedded tissue specimens of 39 MCC for the presence of MCPyV by PCR. We applied four different primer sets directed against the large T antigen and the VP1 gene of MCPyV. We were able to detect MCPyV in 77% (n = 30) of MCC as confirmed by sequence analyses of the PCR products. Sequence analyses showed only minor nucleotide changes compared with the previously published MCC sequences. In addition, one patient revealed the amplification of two PCR products using PCR primers directed against the VP1 gene. Sequence analyses confirmed the presence of the expected 351-bp PCR product and in addition a second PCR product of 261 bp containing a unique 90-bp deletion in the VP1 gene, which will lead to a predicted loss of 28 amino acids. The unique 90-bp deletion within the VP1 gene possibly is a result of incomplete viral integration of MCPyV in the MCC. The presence of MCPyV in the majority of MCC tissue specimens in our study strongly underlines a possible role for MCPyV as an etiologic agent in the carcinogenesis of MCC. [Cancer Res 2008;68(13):5009–13]
This article has been cited by other articles:
![]() |
H. Sihto, H. Kukko, V. Koljonen, R. Sankila, T. Bohling, and H. Joensuu Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma J Natl Cancer Inst, July 1, 2009; 101(13): 938 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shuda, H. Feng, H. J. Kwun, S. T. Rosen, O. Gjoerup, P. S. Moore, and Y. Chang T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus PNAS, October 21, 2008; 105(42): 16272 - 16277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. zur Hausen A specific signature of Merkel cell polyomavirus persistence in human cancer cells PNAS, October 21, 2008; 105(42): 16063 - 16064. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |